Humana Q2 Earnings: Analysts Expect 9.2% EPS Decline and 8.2% Revenue Growth
ByAinvest
Tuesday, Jul 29, 2025 1:16 am ET1min read
CNC--
Key Metrics:
- Revenues-Premiums: Analysts predict this metric to reach $30.23 billion, a 7.4% YoY increase.
- Revenues-Services: This is estimated to reach $1.31 billion, a 19% YoY increase.
- Revenues-Investment Income (Loss): Expected to be $270.96 million, down 9.1% YoY.
- Revenue-Insurance: Predicted to be $30.71 billion.
- Medical Membership-Medicare Stand-Alone PDP: Expected to reach 2.45 million.
The consensus estimate for full-year 2025 revenues is $126.1 billion, a 7.6% YoY increase, with current year EPS pegged at $16.37, implying a 1% YoY gain [2]. Humana has beaten earnings estimates in the past four quarters, with an average surprise of 14.3% [3].
Peer Performance:
- Centene Corporation (CNC) reported a loss of 16 cents per share, missing the Zacks Consensus Estimate.
- Molina Healthcare (MOH) reported adjusted EPS of $5.48, missing the estimate by 1.1%.
- Elevance Health (ELV) reported adjusted EPS of $8.84, missing the estimate by 3.5%.
Humana's earnings are expected to be driven by premium growth and service revenues, while investment income and operating costs are anticipated to have a negative impact. The company's Zacks Rank is #3, and it has an Earnings ESP of +10.51%, increasing the odds of an earnings beat [1].
References:
[1] https://finance.yahoo.com/news/humana-beat-q2-earnings-estimates-152600292.html
[2] https://www.tradingview.com/news/zacks:71aefa8d1094b:0-can-humana-beat-q2-earnings-estimates-on-insurance-unit-strength/
[3] https://www.nasdaq.com/articles/curious-about-humana-hum-q2-performance-explore-wall-street-estimates-key-metrics
ELV--
HUM--
MOH--
Humana (HUM) Q2 earnings expected to decline 9.2% YoY to $6.32/share, with revenues forecast to increase 8.2% YoY to $31.78 billion. Analysts predict specific metrics such as 'Revenues-Premiums' to reach $30.23 billion, a 7.4% YoY change, and 'Medical Membership-Medicare stand-alone PDP' to reach 2.45 million.
Humana Inc. (HUM) is set to report its second-quarter 2025 earnings on July 30, with analysts predicting a 9.2% year-over-year (YoY) decline in earnings per share (EPS) to $6.32. Revenue is forecast to increase by 8.2% YoY to $31.78 billion [1].Key Metrics:
- Revenues-Premiums: Analysts predict this metric to reach $30.23 billion, a 7.4% YoY increase.
- Revenues-Services: This is estimated to reach $1.31 billion, a 19% YoY increase.
- Revenues-Investment Income (Loss): Expected to be $270.96 million, down 9.1% YoY.
- Revenue-Insurance: Predicted to be $30.71 billion.
- Medical Membership-Medicare Stand-Alone PDP: Expected to reach 2.45 million.
The consensus estimate for full-year 2025 revenues is $126.1 billion, a 7.6% YoY increase, with current year EPS pegged at $16.37, implying a 1% YoY gain [2]. Humana has beaten earnings estimates in the past four quarters, with an average surprise of 14.3% [3].
Peer Performance:
- Centene Corporation (CNC) reported a loss of 16 cents per share, missing the Zacks Consensus Estimate.
- Molina Healthcare (MOH) reported adjusted EPS of $5.48, missing the estimate by 1.1%.
- Elevance Health (ELV) reported adjusted EPS of $8.84, missing the estimate by 3.5%.
Humana's earnings are expected to be driven by premium growth and service revenues, while investment income and operating costs are anticipated to have a negative impact. The company's Zacks Rank is #3, and it has an Earnings ESP of +10.51%, increasing the odds of an earnings beat [1].
References:
[1] https://finance.yahoo.com/news/humana-beat-q2-earnings-estimates-152600292.html
[2] https://www.tradingview.com/news/zacks:71aefa8d1094b:0-can-humana-beat-q2-earnings-estimates-on-insurance-unit-strength/
[3] https://www.nasdaq.com/articles/curious-about-humana-hum-q2-performance-explore-wall-street-estimates-key-metrics

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet